OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Elevated interleukin‐11 in systemic sclerosis and role in disease pathogenesis
Thomas Steadman, Steven O’Reilly
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1255-1261
Open Access | Times Cited: 13
Thomas Steadman, Steven O’Reilly
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1255-1261
Open Access | Times Cited: 13
Showing 13 citing articles:
Understanding interleukin 11 as a disease gene and therapeutic target
Stuart A. Cook
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1987-2008
Open Access | Times Cited: 23
Stuart A. Cook
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1987-2008
Open Access | Times Cited: 23
Transforming growth factor beta induces interleukin-11 expression in osteoarthritis
Juliane Lokau, Miriam Bollmann, Yvonne Garbers, et al.
Cytokine (2025) Vol. 187, pp. 156863-156863
Open Access
Juliane Lokau, Miriam Bollmann, Yvonne Garbers, et al.
Cytokine (2025) Vol. 187, pp. 156863-156863
Open Access
Promoting ER stress in a plasmacytoid dendritic cell line drives fibroblast activation
Beatriz H. Ferreira, Inês S. Silva, Andreia Mendes, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Beatriz H. Ferreira, Inês S. Silva, Andreia Mendes, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
Steven O’Reilly
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 2, pp. 154-161
Open Access | Times Cited: 7
Steven O’Reilly
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 2, pp. 154-161
Open Access | Times Cited: 7
Emerging therapeutic targets in systemic sclerosis
Steven O’Reilly
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 465-478
Closed Access | Times Cited: 1
Steven O’Reilly
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 465-478
Closed Access | Times Cited: 1
Cytotoxic and Immunomodulatory Effects of Hypericin as a Photosensitizer in Photodynamic Therapy Used on Skin Cell Cultures
Magdalena Krupka, Andrzej Bożek, Zenon Czuba, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 696-696
Open Access | Times Cited: 1
Magdalena Krupka, Andrzej Bożek, Zenon Czuba, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 696-696
Open Access | Times Cited: 1
Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis
Tatiana V. Kirichenko, Anastasia I. Bogatyreva, Е. В. Герасимова, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 1
Tatiana V. Kirichenko, Anastasia I. Bogatyreva, Е. В. Герасимова, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 1
Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease
Wenyu Zhang, Qili Peng, Xian Huang, et al.
PNAS Nexus (2024) Vol. 3, Iss. 7
Open Access | Times Cited: 1
Wenyu Zhang, Qili Peng, Xian Huang, et al.
PNAS Nexus (2024) Vol. 3, Iss. 7
Open Access | Times Cited: 1
The role of interleukin-6 classic and trans-signaling and interleukin-11 classic signaling in gastric cancer cells
Josephine Runge, Christoph Garbers, Juliane Lokau
Współczesna Onkologia (2024) Vol. 28, Iss. 2, pp. 105-113
Open Access | Times Cited: 1
Josephine Runge, Christoph Garbers, Juliane Lokau
Współczesna Onkologia (2024) Vol. 28, Iss. 2, pp. 105-113
Open Access | Times Cited: 1
IL-11 Expression in Systemic Sclerosis Is Dependent on Caspase-1 Activity but Does Not Increase Collagen Deposition
Caya M. McFalls, Lianne M. Connolly, Alfred G. Fustakgi, et al.
Rheumato (2024) Vol. 4, Iss. 4, pp. 163-175
Open Access
Caya M. McFalls, Lianne M. Connolly, Alfred G. Fustakgi, et al.
Rheumato (2024) Vol. 4, Iss. 4, pp. 163-175
Open Access
Mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis: role and therapeutic directions
Xuan Wang, Jiaying Guo, Qinggang Dai
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Xuan Wang, Jiaying Guo, Qinggang Dai
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Xingpeng Di, Ya Li, Jingwen Wei, et al.
Advanced Science (2024)
Open Access
Xingpeng Di, Ya Li, Jingwen Wei, et al.
Advanced Science (2024)
Open Access
Aberrant Chitinase 3‐Like 1 Expression in Basal Cells Contributes to Systemic Sclerosis Fibrosis
Xiuyuan Wang, Tianbao Ye, Junxia Huang, et al.
Advanced Science (2024)
Open Access
Xiuyuan Wang, Tianbao Ye, Junxia Huang, et al.
Advanced Science (2024)
Open Access
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases
Su Jiang, Julianna Desmarais, Cong‐Qiu Chu, et al.
Best Practice & Research Clinical Rheumatology (2024) Vol. 38, Iss. 2, pp. 101945-101945
Closed Access
Su Jiang, Julianna Desmarais, Cong‐Qiu Chu, et al.
Best Practice & Research Clinical Rheumatology (2024) Vol. 38, Iss. 2, pp. 101945-101945
Closed Access
